NM_206937.2:c.2569G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_206937.2(LIG4):​c.2569G>A​(p.Ala857Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00556 in 1,614,144 control chromosomes in the GnomAD database, including 460 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 237 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 223 hom. )

Consequence

LIG4
NM_206937.2 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.66

Publications

17 publications found
Variant links:
Genes affected
LIG4 (HGNC:6601): (DNA ligase 4) The protein encoded by this gene is a DNA ligase that joins single-strand breaks in a double-stranded polydeoxynucleotide in an ATP-dependent reaction. This protein is essential for V(D)J recombination and DNA double-strand break (DSB) repair through nonhomologous end joining (NHEJ). This protein forms a complex with the X-ray repair cross complementing protein 4 (XRCC4), and further interacts with the DNA-dependent protein kinase (DNA-PK). Both XRCC4 and DNA-PK are known to be required for NHEJ. The crystal structure of the complex formed by this protein and XRCC4 has been resolved. Defects in this gene are the cause of LIG4 syndrome. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Jul 2008]
LIG4 Gene-Disease associations (from GenCC):
  • DNA ligase IV deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • Dubowitz syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Omenn syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017314553).
BP6
Variant 13-108208700-C-T is Benign according to our data. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-108208700-C-T is described in CliVar as Benign. Clinvar id is 310973.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LIG4NM_206937.2 linkc.2569G>A p.Ala857Thr missense_variant Exon 3 of 3 ENST00000442234.6 NP_996820.1 P49917A0A024RE06

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LIG4ENST00000442234.6 linkc.2569G>A p.Ala857Thr missense_variant Exon 3 of 3 1 NM_206937.2 ENSP00000402030.1 P49917

Frequencies

GnomAD3 genomes
AF:
0.0300
AC:
4562
AN:
152170
Hom.:
234
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0113
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.00771
AC:
1938
AN:
251442
AF XY:
0.00552
show subpopulations
Gnomad AFR exome
AF:
0.107
Gnomad AMR exome
AF:
0.00468
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000158
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00300
AC:
4381
AN:
1461854
Hom.:
223
Cov.:
33
AF XY:
0.00254
AC XY:
1844
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.108
AC:
3615
AN:
33474
American (AMR)
AF:
0.00512
AC:
229
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000890
AC:
99
AN:
1112002
Other (OTH)
AF:
0.00669
AC:
404
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
241
483
724
966
1207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0302
AC:
4598
AN:
152290
Hom.:
237
Cov.:
32
AF XY:
0.0297
AC XY:
2215
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.105
AC:
4362
AN:
41548
American (AMR)
AF:
0.0112
AC:
172
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68024
Other (OTH)
AF:
0.0217
AC:
46
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
206
411
617
822
1028
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0125
Hom.:
231
Bravo
AF:
0.0342
ESP6500AA
AF:
0.100
AC:
442
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00957
AC:
1162
Asia WGS
AF:
0.00895
AC:
31
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DNA ligase IV deficiency Benign:3
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Severe combined immunodeficiency due to DCLRE1C deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.061
T;T;T;T;.
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.16
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.83
.;.;.;T;T
MetaRNN
Benign
0.0017
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;M;M;M;.
PhyloP100
1.7
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.88
N;.;N;N;.
REVEL
Benign
0.13
Sift
Benign
0.13
T;.;T;T;.
Sift4G
Uncertain
0.043
D;D;D;D;D
Polyphen
0.0030
B;B;B;B;.
Vest4
0.055
MVP
0.69
MPC
0.048
ClinPred
0.014
T
GERP RS
2.9
Varity_R
0.067
gMVP
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2232642; hg19: chr13-108861048; API